|Bid||33.01 x 1000|
|Ask||35.14 x 1200|
|Day's Range||34.37 - 35.28|
|52 Week Range||17.01 - 38.96|
|Beta (5Y Monthly)||1.44|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 02, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||37.86|
Ingersoll Rand (IR) Q3 earnings are expected to have gained from solid medical end markets, strong product portfolio and innovation capabilities despite the coronavirus outbreak-led issues.
Ingersoll (IR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingersoll (IR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.